Pathophysiology Core
Pathophysiology Core
批准号:
10224330
负责人:
Rubin M. Tuder
金额:
$17.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-01 至 2025-06-30
关键词:
Animal ModelAnimalsBlood VesselsCellular StructuresCollectionComplementComplement ActivationComplement component C8DataDiseaseFunctional disorderGenomicsGoalsHistologicHumanImageImmuneImmune systemImmunofluorescence ImmunologicImmunohistochemistryInflammationInflammatoryInvestigationLabelLeadershipLesionLungMalignant NeoplasmsMass Spectrum AnalysisMediatingMessenger RNAMethodologyMethodsModelingMorphologyMusNewborn InfantPathologistPathologyPatternPhenotypePreparationProteinsProteomeProteomicsPulmonary HypertensionRNARattusResearch PersonnelResourcesRoleSamplingServicesStructureSystemTranslatingTranslationsVascular DiseasesVascular remodelingbaseexperienceexperimental studyhigh throughput analysishuman tissueimaging approachinflammatory markerinnovationlaser capture microdissectionmemberpathology imagingtargeted imagingtissue processingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The primary objective of the Pathology and Imaging Core is to provide accurate phenotypic characterization of
pulmonary vascular remodeling, document activation of complement, assess inflammation, and isolate mRNA
and proteins, in diseased IPAH human lungs and relevant models of PH. To accomplish these goals, we will
perform 8 tasks based on specific methodologies, aimed at integrating high quality tissue processing,
immunohistochemistry, and stereology with high throughput imaging approaches and laser capture
microdissection for all 4 projects in this PPG.
Aim 1: To provide qualitative and quantitative assessment of pulmonary vascular remodeling in lungs
of humans, steers and newborn calves, rats, and mice in Projects 1-4. We propose 4 specific tasks to
support this specific aim, which include: planning of experiments (task 1), collection, processing, and
phenotyping experimental lungs (task 2), morphology and stereology of pulmonary vascular remodeling (task
4), and integration of morphological data with specific project goals and aims (task 8).
Aim 2: To determine expression patterns and abundance of candidate molecules investigated in
experimental lungs. We propose 5 specific tasks to support this specific aim, which include planning of
experiments (task 1), tissue processing (task 2), morphology and stereology (task 3), laser capture
microdissection (LCM; task 7), and integration of morphological data with project goals and aims (task 8).
Aim 3: Specific Aim 3: To obtain high quality mRNA and protein for transcriptomic and proteomic
studies from specific pulmonary vascular structures and lesions from animals manipulated in Projects
1-4. We propose 5 specific tasks to support this specific aim, which include planning of experiments (task 1),
tissue processing (task 2), LCM (task 7), and integration of morphological data with specific project goals and
aims (task 8).
Aim 4: To translate the key expression findings in Specific Aim 2 to human control and PAH lungs. We
propose six specific tasks to support the specific aim, which include planning of experiments (task1), tissue
processing (task 2), human tissue studies (task 3), morphology and stereology (task 4), LCM (task 7), and
integration of morphological data with specific project goals and aims (task 8).
Foremost in accomplishing these goals is the scientific expertise within the leadership of the core. The
Pathology and Imaging Core is led by of Drs. Rubin M. Tuder, an experimental and practicing pulmonary
pathologist with major expertise in pathology and pathobiology of pulmonary hypertension, with the support of
Dr. Raphe Nemenoff, an experienced investigator in the cancer field with expertise in multiprobe immune
imaging targeting the immune system and complement. The novelty of the Pathology and Imaging Core lies
on the unique resources, unmatched expertise, and overall experimental breadth, allowing for the integration
and human translation pertaining to all four projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
-
批准号:10224333
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2020
-
负责人:Rubin M. Tuder
-
依托单位:
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
-
批准号:10470738
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2020
-
负责人:Rubin M. Tuder
-
依托单位:
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
-
批准号:10686936
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2020
-
负责人:Rubin M. Tuder
-
依托单位:
Pathophysiology Core
-
批准号:10470734
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2020
-
负责人:Rubin M. Tuder
-
依托单位:
Pathophysiology Core
-
批准号:10686928
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2020
-
负责人:Rubin M. Tuder
-
依托单位:
54th Annual Thomas L. Petty Aspen Lung Conference: COPD and Lung Cancer: Common P
-
批准号:8129411
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:Rubin M. Tuder
-
依托单位:
RTP-801 in Cigarette Smoke-Emphysema
-
批准号:8230483
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2011
-
负责人:Rubin M. Tuder
-
依托单位:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
-
批准号:8676740
-
项目类别:
-
资助金额:$58.04万
-
财政年份:2011
-
负责人:Rubin M. Tuder
-
依托单位:
RTP-801 in Cigarette Smoke-Emphysema
-
批准号:8064153
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2011
-
负责人:Rubin M. Tuder
-
依托单位:
RTP-801 in Cigarette Smoke-Emphysema
-
批准号:8396393
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2011
-
负责人:Rubin M. Tuder
-
依托单位:
Microbiome in Chronic Obstructive Pulmonary Disease
-
批准号:7713377
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2009
-
负责人:Rubin M. Tuder
-
依托单位:
Zipcode based nano-imaging of hypertensive pulmonary arteries
-
批准号:7935441
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Rubin M. Tuder
-
依托单位:
Microbiome in Chronic Obstructive Pulmonary Disease
-
批准号:7837629
-
项目类别:
-
资助金额:$7.65万
-
财政年份:2009
-
负责人:Rubin M. Tuder
-
依托单位:
Zipcode based nano-imaging of hypertensive pulmonary arteries
-
批准号:7830546
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Rubin M. Tuder
-
依托单位:
MOLECULAR PATHOPHYSIOLOGY CORE
-
批准号:7499947
-
项目类别:
-
资助金额:$27.16万
-
财政年份:2007
-
负责人:Rubin M. Tuder
-
依托单位:
CORE--MOLECULAR PATHOLOGY
-
批准号:7394294
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2007
-
负责人:Rubin M. Tuder
-
依托单位:
Novel Protective Antiapoptotic Action of Alpha 1-Antitrypsin In Emphysema
-
批准号:7246941
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:Rubin M. Tuder
-
依托单位:
Discovery of biomarkers of pulmonary hypertension
-
批准号:6818878
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2004
-
负责人:Rubin M. Tuder
-
依托单位:
Discovery of biomarkers of pulmonary hypertension
-
批准号:6905604
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2004
-
负责人:Rubin M. Tuder
-
依托单位:
Core--Molecular Pathology
-
批准号:6820152
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2003
-
负责人:Rubin M. Tuder
-
依托单位:
海外基金